Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
Serena Mancarella, Grazia Serino, Francesco Dituri, et al.
Cell Death and Differentiation (2020) Vol. 27, Iss. 8, pp. 2330-2343
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 68
Chromosome evolution screens recapitulate tissue-specific tumor aneuploidy patterns
Emma V. Watson, Jake June-Koo Lee, D. Gulhan, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 900-912
Open Access | Times Cited: 17
Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy
Nimeet Desai, Deepak Kumar Sahel, Bhakti Kubal, et al.
Advanced Therapeutics (2025)
Open Access | Times Cited: 3
Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives
Gillian Moore, Stephanie Annett, Lana McClements, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1503-1503
Open Access | Times Cited: 115
Evolution of the Experimental Models of Cholangiocarcinoma
Annamaria Massa, Chiara Varamo, Francesca Vita, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2308-2308
Open Access | Times Cited: 89
Microglia exosomal miRNA-137 attenuates ischemic brain injury through targeting Notch1
Dianquan Zhang, Guoliang Cai, Kai Liu, et al.
Aging (2021) Vol. 13, Iss. 3, pp. 4079-4095
Open Access | Times Cited: 77
Therapeutic Targeting of Notch Signaling: From Cancer to Inflammatory Disorders
Frederick H. Allen, Ivan Maillard
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 62
Notch‐triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase
Zhiqiang Fang, Bai Ruan, Jingjing Liu, et al.
Hepatology (2022) Vol. 76, Iss. 3, pp. 742-758
Closed Access | Times Cited: 46
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 15
Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics
Dia Advani, Sudhanshu Sharma, Smita Kumari, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 433-468
Closed Access | Times Cited: 48
Patient-Derived Organoids of Cholangiocarcinoma
Christopher Maier, Lei Zhu, Lahiri Kanth Nanduri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8675-8675
Open Access | Times Cited: 45
Reprogramming of cancer-associated fibroblasts by apoptotic cancer cells inhibits lung metastasis via Notch1-WISP-1 signaling
Hee Ja Kim, Kyungwon Yang, Kiyoon Kim, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 12, pp. 1373-1391
Open Access | Times Cited: 32
Familial Alzheimer’s disease-associated PSEN1 mutations affect neurodevelopment through increased Notch signaling
Erin M. Hurley, Paweł Mozolewski, Radek Dobrowolski, et al.
Stem Cell Reports (2023) Vol. 18, Iss. 7, pp. 1516-1533
Open Access | Times Cited: 21
Emerging Therapies in Management of Cholangiocarcinoma
Jessica Speckart, Veronica Rasmusen, Zohray Talib, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 613-613
Open Access | Times Cited: 7
Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition
Noah Federman
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 28
FSTL1-USP10-Notch1 Signaling Axis Protects Against Cardiac Dysfunction Through Inhibition of Myocardial Fibrosis in Diabetic Mice
Linhe Lu, Jipeng Ma, Liu Yang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 29
Migraine as an inflammatory disorder with microglial activation as a prime candidate
Amrit Sudershan, Mohd Younis, Srishty Sudershan, et al.
Neurological Research (2022) Vol. 45, Iss. 3, pp. 200-215
Closed Access | Times Cited: 19
Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies
Jian‐Yang Ao, Mingtai Hu, Jinghan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
Peeranate Vanaroj, Wanna Chai่jaroenkul, Kesara Na‐Bangchang
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 2, pp. 551-558
Open Access | Times Cited: 8
Circulating tumour cell clusters: isolation, biological significance and therapeutic implications
Y. Richard Yang, Guanyin Huang, Jingru Lian, et al.
BMJ Oncology (2024) Vol. 3, Iss. 1, pp. e000437-e000437
Open Access | Times Cited: 3
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
Serena Mancarella, Grazia Serino, Isabella Gigante, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 13
Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition
Serena Mancarella, Isabella Gigante, Grazia Serino, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 13
Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest
Serena Mancarella, Isabella Gigante, Elena Antinoro Pizzuto, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Secretase promotes AD progression: simultaneously cleave Notch and APP
Ke-Fan Yang, Jingyi Zhang, Mei Feng, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top